ZK-164015 (BRD-K05151076)
Overview
- pert_id
- BRD-K05151076
- Name
- ZK-164015
- Synonyms
- ZK-164015
- Collection
- BIOA
- MOA
- estrogen receptor antagonist
- Target(s)
- ESR1, ESR2
- Indication(s)
- Unknown
- Phase
- Preclinical
- Canonical SMILES
- CCCCCS(=O)(=O)CCCCCCCCCCn1c(c(C)c2cc(O)ccc12)c3ccc(O)cc3
- InChI key
- InChIKey=LYJSJVYJLZOMCD-UHFFFAOYSA-N
- InChI string
- InChI=1S/C30H43NO4S/c1-3-4-12-21-36(34,35)22-13-10-8-6-5-7-9-11-20-31-29-19-18-27(33)23-28(29)24(2)30(31)25-14-16-26(32)17-15-25/h14-19,23,32-33H,3-13,20-22H2,1-2H3
- Molecular formula
- C30H43NO4S
- Molecular weight
- 513.732
External links
- PubChem
- 9806489
- SEP-L1000
- BRD-K05151076
Predicted MOAs
| MOA | Probability |
|---|---|
| dopamine receptor antagonist | 0.0993 |
| adrenergic receptor antagonist | 0.0878 |
| mTOR inhibitor | 0.0672 |
| histamine receptor antagonist | 0.0549 |
| CDK inhibitor | 0.0548 |
| NFkB pathway inhibitor | 0.0536 |
| cyclooxygenase inhibitor | 0.0490 |
| protein synthesis inhibitor | 0.0475 |
| estrogen receptor agonist | 0.0449 |
| glucocorticoid receptor agonist | 0.0416 |
Chemical structure
